Protection of Chinese painted quails (Coturnix chinensis) against a highly pathogenic H5N1 avian influenza virus strain after vaccination
- PMID: 23771736
- PMCID: PMC3830747
- DOI: 10.1007/s00705-013-1754-z
Protection of Chinese painted quails (Coturnix chinensis) against a highly pathogenic H5N1 avian influenza virus strain after vaccination
Abstract
Chinese painted quails immunized with a single dose (6 μg HA) of inactivated H5N1 (clade 1) influenza vaccine NIBRG-14 and challenged with 100 LD50 of the heterologous A/Swan/Nagybaracska/01/06(H5N1) (clade 2.2) strain were protected, whereas unvaccinated quails died after challenge. No viral antigens or RNA were detected in cloacal swabs from immunized animals. Sera obtained post-immunization gave low titres in serological assays against the vaccine and the challenge viruses. Our results demonstrate the protective efficacy of the NIBRG-14 strain against the challenge virus and the usefulness of these small birds in protection studies of influenza vaccines.
Figures

Similar articles
-
Single dose of oil-adjuvanted inactivated vaccine protects chickens from lethal infections of highly pathogenic H5N1 influenza virus.Vaccine. 2011 Mar 3;29(11):2178-86. doi: 10.1016/j.vaccine.2010.12.013. Epub 2010 Dec 18. Vaccine. 2011. PMID: 21172378
-
Antibody titer has positive predictive value for vaccine protection against challenge with natural antigenic-drift variants of H5N1 high-pathogenicity avian influenza viruses from Indonesia.J Virol. 2015 Apr;89(7):3746-62. doi: 10.1128/JVI.00025-15. Epub 2015 Jan 21. J Virol. 2015. PMID: 25609805 Free PMC article.
-
A two dose immunization with an inactivated reassortant H5N2 virus protects chickens against lethal challenge with homologous 2.3.2.1 clade and heterologous 2.2 clade highly pathogenic avian influenza H5N1 viruses.Vet Microbiol. 2018 Apr;217:149-157. doi: 10.1016/j.vetmic.2018.03.004. Epub 2018 Mar 13. Vet Microbiol. 2018. PMID: 29615248
-
Protective Efficacy of Recombinant Turkey Herpes Virus (rHVT-H5) and Inactivated H5N1 Vaccines in Commercial Mulard Ducks against the Highly Pathogenic Avian Influenza (HPAI) H5N1 Clade 2.2.1 Virus.PLoS One. 2016 Jun 15;11(6):e0156747. doi: 10.1371/journal.pone.0156747. eCollection 2016. PLoS One. 2016. PMID: 27304069 Free PMC article.
-
Vaccination of birds other than chickens and turkeys against avian influenza.Rev Sci Tech. 2009 Apr;28(1):307-18. doi: 10.20506/rst.28.1.1872. Rev Sci Tech. 2009. PMID: 19618634 Review.
Cited by
-
A Reduced Dose Whole Virion Aluminum Adjuvanted Seasonal Influenza Vaccine Is Immunogenic, Safe, and Well Tolerated in Pediatric Patients.Viruses. 2021 Mar 18;13(3):500. doi: 10.3390/v13030500. Viruses. 2021. PMID: 33803680 Free PMC article. Clinical Trial.
-
Evaluation of Vaccine Immunogenicity-Correlates to Real-World Protection: Influenza.Viruses. 2024 Mar 12;16(3):441. doi: 10.3390/v16030441. Viruses. 2024. PMID: 38543806 Free PMC article. Review.
References
-
- Bright RA, Carter DM, Crevar CJ, Toapanta FR, Steckbeck FD, Cole KS, Kumar NM, Pushko P, Smith G, Tumpey TM, Ross TM. Cross-clade protective immune respomses to influenza viruses with H5N1 HA and NA elicited by an influenza virus-like particle. PLoS ONE. 2008;3(1):e1501. doi: 10.1371/journal.pone.0001501. - DOI - PMC - PubMed
-
- Committee for Proprietary Medicinal Products. 12 March 1997. Note for guidance on harmonisation of requirements for influenza vaccines. CPMP/BWP/214/96. European Agency for the Evaluation of Medicinal Products, London, UK. http://www.emea.europa.eu/pdfs/human/bwp/021496en.pdf
-
- European Committee for Proprietary Medicinal Products. Guideline on dossier structure and content for pandemic influenza vaccine marketing authorisation application (CPMP/VEG/4717/03). European Agency for the Evaluation of Medicinal Products, 2004, London, UK
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical